PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
18942155-7	2008	The developed electrophoretically mediated microanalysis method was applied for the kinetics study of FMO3 using clozapine as a substrate probe.	Clozapine	113-122	flavin containing dimethylaniline monoxygenase 3	Homo sapiens	102-106	
9840430-3	1998	In vitro metabolism of clozapine was investigated using human CYP1A1, CYP1A2, CYP2C8, CYP2E1, CYP2C9-arg144, CYP2C9-cys144, CYP2C19, CYP2D6, CYP3A4, CYP3A5 and FMO3 supplemented with an NADPH generating system.	Clozapine	23-32	flavin containing dimethylaniline monoxygenase 3	Homo sapiens	160-164	
10546928-0	1999	Flavin monooxygenase 3 (FMO3) polymorphism in a white population: allele frequencies, mutation linkage, and functional effects on clozapine and caffeine metabolism.	Clozapine	130-139	flavin containing dimethylaniline monoxygenase 3	Homo sapiens	24-28	
10546928-3	1999	We therefore wanted to analyze population frequencies and allelic linkage of FMO3 mutations and their functional effect on the metabolism of clozapine and caffeine.	Clozapine	141-150	flavin containing dimethylaniline monoxygenase 3	Homo sapiens	77-81	
28084789-3	2017	RESULTS: The apparent Km with clozapine as substrate and inhibition of hFMO3 by methimazole were explored for immobilized hFMO3 and were found to be comparable to literature values.	Clozapine	30-39	flavin containing dimethylaniline monoxygenase 3	Homo sapiens	122-127